UDG Healthcare PLC (LON:UDG) target price raised to 620.00GBX, issued a research note today by Stifel
- Updated: September 27, 2016
Only yesterday UDG Healthcare PLC (LON:UDG) traded 1.44% higher at 633.50GBX. UDG Healthcare PLC’s 50-day average is 624.35GBX and its two hundred day moving average is 599.59GBX. The last closing price is up 5.57% from the 200-day moving average, compared to the S&P 500 which has decreased -0.01% over the same period. Volume of trade was down over the average, with 153,840 shares of UDG changing hands under the typical 503,705
In a report announced on 09/28/2016 Stifel upped the price target of UDG Healthcare PLC (LON:UDG) to 620.00GBX reporting a possible downside of -0.02%.
With a total market value of 0 GBX, UDG Healthcare PLC has PE ratio of 21.53 with a one year low of 452.20GBX and a one year high of 656.50GBX .
A total of 6 firms have released a research note on UDG. 1 brokerage rating the company a strong buy, 6 brokers rating the stock a buy, 1 firm rating the stock a hold, zero analysts rating the company a underperform, and finally zero brokerages rating the stock a sell with a average stock price target of 9.00GBX.
About UDG Healthcare PLC (LON:UDG)
UDG Healthcare plc, formerly United Drug plc, is a healthcare services provider in the Republic of Ireland, the United Kingdom, North America and Continental Europe. The Company operates in three segments. The Ashfield Commercial & Medical Services segment is engaged in the provision of sales, marketing and healthcare communications services to pharmaceutical companies, and it also provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services to over 300 healthcare companies in approximately 20 countries. The Sharp Packaging Services segment is engaged in contract packaging and clinical trial packaging services for the pharmaceutical and biotechnology industries, and also provides Track and Trace serialization services. The Supply Chain Services segment includes Aquilant, a provider of outsourced sales, marketing, distribution and engineering services to the medical and scientific sectors.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.